Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Clayton Taylor currently holds 1,469,482 shares of IDERA PHARMACEUTICALS, INC. (IDRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Clayton Taylor has been a net neutral trader of IDRA stock. They have purchased $0 and sold $0 worth of shares.
John Clayton Taylor's most recent insider trade was on Jan 17, 2023, when they sold 1,341,764 shares at $0.00 per share.
John Clayton Taylor serves as Executive at IDERA PHARMACEUTICALS, INC. (IDRA). They have executed 2 insider transactions totaling $0 over their tenure at the company.
John Clayton Taylor holds the position of Executive at IDERA PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
John Clayton Taylor has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John Clayton Taylor was on Jan 17, 2023, when they sold $0 worth of ACGN shares. This transaction involved 1,341,764 shares at N/A per share.
John Clayton Taylor currently owns 1,469,482 shares of IDERA PHARMACEUTICALS, INC. (IDRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Clayton Taylor's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Clayton Taylor has 2 Form 4 filings on record as an insider at IDERA PHARMACEUTICALS, INC..
Set alerts for John Clayton Taylor and 40,000+ other insiders.